Louisiana 2026 Regular Session Status: In Committee 1 R cosponsors

SB 369 — PHARMACEUTICALS: Provides for prescription drug pricing. (1/1/27) (EG SG EX See Note)

Last action — Read by title and returned to the Calendar, subject to call.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the Senate. Introduced February 27, 2026. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the Senate.

Prognosis

Stalled 16% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • In Committee

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (1 R).

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Bill Text

What changed in the latest version

21 added · 13 removed

Plain-language change summary

The amendments to Bill SB 369 changed the scope of the proposed law to focus specifically on state-sponsored insurance plans, like the Office of Group Benefits, rather than applying to all health insurance reimbursements. This means that manufacturers can only sell drugs at or below the Medicare price for these specific plans. This change is important because it narrows the bill's impact and provides targeted benefits for a specific group of insurance holders, which may simplify enforcement and help control costs for state-funded healthcare.

→
Previous
Latest
SLS 26RS-248 ORIGINAL Regular Session SENATE BILL NO.
SLS 26RS-248 ENGROSSED Regular Session SENATE BILL NO.
B.An insurer,pharmacybenefitmanager,orpersonactingonbehalf of a pharmacy benefit manager shall not provide reimbursement for any name branddrug,biosimilar,orgenericdrugthatislessthanthepriceMedicarepays for the same drug.
B.An insurer,pharmacybenefitmanager,orpersonactingonbehalf of a pharmacy benefit manager shall not provide reimbursement on behalf of an OfficeofGroupBenefitsinsuranceplanoranyotherstatesponsoredinsurance plan for any name brand drug, biosimilar, or generic drug that is less than the price Medicare pays for the same drug.
Section 2.
This Act shall become effective on January 1, 2027.
SLS 26RS-248 ORIGINAL SB NO.
SLS 26RS-248 ENGROSSED SB NO.
369 The original instrument and the following digest, which constitutes no part of the legislative instrument, were prepared bySenate Legislative Services.
369 Section 2.
This Act shall become effective on January 1, 2027.
The original instrument and the following digest, which constitutes no part of the legislative instrument, were prepared bySenate Legislative Services.
1:13(B) and 24:177(E)] DIGEST SB 369 Original 2026 Regular Session Bass Proposedlawprohibitsadrugmanufacturerfromsellingadruginthisstateatahigherprice than the price Medicare pays for the same drug.
1:13(B) and 24:177(E)] DIGEST SB 369 Engrossed 2026 Regular Session Bass Proposedlawprohibits adrugmanufacturerfromsellingadruginthisstateatahigherprice than the price Medicare pays for the same drug of an Office of Group Benefits (OGB) or other state sponsored insurance plan.
Proposed law prohibits an insurer or pharmacy benefit manager from providing reimbursement for any drug less than the price Medicare pays for the same drug.
Proposed law prohibits an insurer or pharmacy benefit manager from providing reimbursement for anydrug less than the price Medicare pays for the same drug of an OGB or other state sponsored insurance plan.
22:1867.1) Page 2 of 2 Coding:
22:1867.1) Summary of Amendments Adopted by Senate CommitteeAmendmentsProposedbySenateCommitteeonInsurancetotheoriginal bill 1.
Limit applicability of proposed law relative to health insurance reimbursements to OGB or state sponsored plans.
Page 2 of 2 Coding:
View plain text versions (2)

Amendments

2 amendments

Click Show changes on an amendment above to see how it modifies the bill.

Action History

  1. Read by title and returned to the Calendar, subject to call.

  2. Read by title. Committee amendments read and adopted. Ordered engrossed and passed to third reading and final passage.

  3. Reported with amendments.

  4. Introduced in the Senate; read by title. Rules suspended. Read second time and referred to the Committee on Insurance.

  5. Prefiled and under the rules provisionally referred to the Committee on Insurance.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 146 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (146)

146 members have not signed on to this bill.

Show all 146 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors SB 369?
SB 369 is sponsored by Adam Bass (Republican).
What is the current status of SB 369?
This bill is in committee in the Senate. Introduced February 27, 2026. It must pass committee before a floor vote.
Where can I track SB 369?
Track SB 369 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 369

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of SB 369

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →